[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360379-105":59,"doc-detail-360379-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrative-chinese-herbal-medicine-as-adjuvant-management-for-triple-negative-breast-cancer-a-multi-institutional-realworld-study-with-mechanism-exploration","Integrative Chinese Herbal Medicine as Adjuvant Management for Triple-Negative Breast Cancer: A Multi-Institutional RealWorld Study With Mechanism Exploration","","Triple-negative breast cancer (TNBC) is a major driver of cancer mortality worldwide, yet the long-term benefit of Chinese herbal medicine (CHM) as adjunctive therapy remains unclear. This multi-institutional real-world cohort drew on the Chang Gung Research Database, tracking TNBC patients diagnosed from 2011 to 2021 for up to 10 years. Overall survival and disease-specific survival were analyzed using Kaplan–Meier methods with overlap weighting and landmark analysis, while core CHMs were proposed via network pharmacology. Results showed improved 10-year overall survival and reduced all-cause mortality risk among CHM users, with lower disease-specific survival and mechanistic candidate herbs for further study.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-chinese-herbal-medicine-as-adjuvant-management-for-triple-negative-breast-cancer-a-multi-institutional-realworld-study-with-mechanism-exploration/360379/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-chinese-herbal-medicine-as-adjuvant-management-for-triple-negative-breast-cancer-a-multi-institutional-realworld-study-with-mechanism-exploration/360379.png","ImageObject",300,407,{"name":92,"@type":93},"eBook King","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s primary question about integrative Chinese herbal medicine in TNBC?","Question",{"text":112,"@type":113},"Whether using Chinese herbal medicine as an adjunct for newly diagnosed triple-negative breast cancer patients improves long-term outcomes, especially survival, and what potential mechanisms may be involved.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were long-term outcomes analyzed in the cohort?",{"text":117,"@type":113},"Overall survival and disease-specific survival were assessed using Kaplan–Meier estimation with overlap weighting and landmark analysis to reduce bias.",{"name":119,"@type":110,"acceptedAnswer":120},"What survival effects were observed for patients who used CHM?",{"text":121,"@type":113},"CHM use was associated with higher 10-year overall survival compared with non-users and a reduced risk of all-cause mortality after adjusting for demographic factors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360379,1790335313,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Integrative Chinese Herbal Medicine as Adjuvant Management for Triple-Negative Breast Cancer: A Multi-Institutional RealWorld Study With Mechanism Exploration  \nHsiang-I Hou, MD 1, Hsu-Huan Chou, MD2, Chao-Wei Lee, PhD2, and Hsing-Yu Chen, PhD 1,3  \nIntegrative Cancer Therapies Volume 25: 1–19 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/15347354261451843](DOI: 10.1177/15347354261451843)[ ](DOI: 10.1177/15347354261451843)[journals.sagepub.com/home/ict](journals.sagepub.com/home/ict)  \nAbstract  \nBackground: Triple-negative breast cancer (TNBC) is a major cause of mortality worldwide. Chinese herbal medicine (CHM) is often used as adjunctive therapy, but its long-term impact on TNBC remains unclear.  \nMaterials and methods: This study analyzed a multi-institutional cohort from the Chang Gung Research Database, investigating long-term outcomes of integrative CHM use in TNBC patients newly diagnosed between January 1, 2011, and December 31, 2021. Patients were followed for up to 10 years or until death. Overall survival rate (OS) and disease-specific survival rates were assessed using Kaplan–Meier estimation with overlap weighting and landmark analysis to reduce bias. Core CHMs were identified through network pharmacology analysis on prescriptions made for TNBC patients.  \nResults: The analysis included 2174 TNBC patients, with 464 using CHM. CHM use was associated with a significantly higher 10-year OS compared to non-users (77.7% vs 70.2%, P = .007). In stages 1 to 3, the OS among CHM users was 6.6% higher (80.7% vs 74.1%, P = .018). After adjusting for demographic factors, CHM use reduced the risk of all-cause mortality (adjusted hazard ratio [aHR]: 0.71, P = .044). Lower disease-specific survival rates were observed among CHM users. Core CHMs, such as Hedyotis diffusa Willd., may have potential anti-cancer effects, while combinations like Jia-Wei-Xiao-Yao-San, Scutellaria barbata D. Don. and Suan-Zao-Ren-Tang may have a complementary role to standard treatments for TNBC.  \nConclusion: Use of CHM may improve 10-year OS in TNBC patients, and core CHMs provided crucial references for further studies.  \nKeywords  \nChinese herbal medicine, Chinese herbal medicine network, pharmacology network, triple negative breast cancer, survival analysis  \nReceived: July 22, 2025; accepted: May 4, 2026  \nIntroduction  \nBreast cancer poses a substantial global health challenge. In 2020, it was the most commonly diagnosed cancer worldwide, with an estimated 2.26 million cases, and was the leading cause of cancer-related mortality among women.1 Additionally, it ranked as the fifth leading cause of cancerrelated mortality globally, regardless of sex, contributing to 685 000 deaths.2 According to the cancer registry report from Taiwan’s Ministry of Health and Welfare, breast cancer was the most prevalent malignant tumor and the second leading cause of death among women in Taiwan in 2021.3  \nEach year in Taiwan, over 10 000 women are diagnosed with breast cancer, and nearly 3000 women succumb to the disease. In 2021 alone, 18 182 newly diagnosed cases and  \n1 Chang Gung Memorial Hospital, Taoyuan, Taiwan 2Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan 3Chang Gung University, Taoyuan, Taiwan  \nCorresponding Author:  \nHsing-Yu Chen, Department of Chinese Internal Medicine, Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, No. 123, Dinghu Rd., Guishan Dist, Taoyuan City 33378, Taiwan.  \nEmail: [b8705016@gmail.com](b8705016@gmail.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons AttributionNonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original wor","cbCaio47nLV0KUk1","https://ap.wps.com/l/cbCaio47nLV0KUk1","pdf",2763904,"English","# Abstract\n# Introduction\n## Background on breast cancer and TNBC\n# Materials and methods\n# Results\n# Conclusion","[{\"question\":\"What was the study’s primary question about integrative Chinese herbal medicine in TNBC?\",\"answer\":\"Whether using Chinese herbal medicine as an adjunct for newly diagnosed triple-negative breast cancer patients improves long-term outcomes, especially survival, and what potential mechanisms may be involved.\"},{\"question\":\"How were long-term outcomes analyzed in the cohort?\",\"answer\":\"Overall survival and disease-specific survival were assessed using Kaplan–Meier estimation with overlap weighting and landmark analysis to reduce bias.\"},{\"question\":\"What survival effects were observed for patients who used CHM?\",\"answer\":\"CHM use was associated with higher 10-year overall survival compared with non-users and a reduced risk of all-cause mortality after adjusting for demographic factors.\"}]","Integrative Chinese Herbal Medicine as Adjuvant Management for Triple-Negative Breast Cancer: A Multi-Institutional RealWorld Study With Mechanism Exploration | PDF",1790139856,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc36f55c7fb683613495f745fc4e14c4.webp",983,1276,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed9802a027b02a9c8d4803702b249210.webp",982,1275,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c198ff3ab2153cc8937cb8658e99c87.webp",981,1273,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ceac123a37384ceeca60325af7bbb15.webp",980,1272]